Clinical trials
Hospitalized Patients clinical trials
Below are recruiting hospitalized patients clinical trials, each written for real people, not researchers. We’re tracking 3,422 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04182087Recruiting
Testing thinking skills after a localized brain injury
This trial studies how your thinking and memory abilities work after a single, localized brain injury seen on MRI. It involves cognitive (thinking) tasks to assess changes and may help researchers understand brain function after injury.
GrenobleAges 18–70 - NCT07861685Recruiting
Recovery aid after severe preeclampsia
This study tests whether a medicine called furosemide (a water pill) helps women recover faster after giving birth with severe preeclampsia. If you join, you'll take the medicine or a placebo to see if it improves your recovery.
Peshawar, Khyber PakhtunkhwaAges 18–45 - NCT06300541Recruiting
Sarcopenia in inflammatory bowel disease flare-ups
This study looks at how common muscle loss (sarcopenia) is in people with inflammatory bowel disease during a flare-up, and what impact it has. By participating, you may help doctors better understand and treat muscle weakness in IBD.
GothenburgAges 18 years+ - NCT06054321Recruiting
Depression medication study for adults 19 to 65
This study tests a new way of choosing antidepressants for people with major depression. It's designed for adults aged 19–65 who have moderate to severe depression and are either starting a new antidepressant or have been off psychiatric meds for at least a month.
GwangjuAges 19–65 - NCT01600378Recruiting
A study to collect health data in lung disease
This study follows adults who have suspected diffuse lung disease (abnormal changes in multiple areas of the lungs) and collects health information over time. It may help doctors better understand these lung conditions and how they progress.
SingaporeAges 21–90 - NCT06375161RecruitingEarly Phase 1
CAR-T cells for relapsed B-cell cancers
This early-phase trial tests a type of immunotherapy called anti-CD19 CAR-T cells. These are specially engineered immune cells that seek out and destroy cancer cells with a marker called CD19 on their surface. It is for people with B-cell cancers (leukemia or lymphoma) that have not responded to or come back after standard treatments.
Shanghai, Shanghai MunicipalityAges 4 months–1.3 years - NCT06161701Recruiting
Steroid-related diabetes in kidney disease patients
This trial looks at how steroids affect blood sugar in people with certain kidney diseases. If you are starting steroid treatment, this study may help understand and manage the risk of developing diabetes.
Hangzhou, ZhejiangAges 18–75 - NCT04700358Recruiting
Study of antibacterial antibodies in adults with cystic fibrosis
This study looks at how your body’s antibacterial antibodies work in people with cystic fibrosis. It may help researchers understand immune responses in cystic fibrosis and guide better future treatments.
CologneAges 18 years+ - NCT07823842Recruiting
Biologics for asthma and COPD
This study looks at how well medicines called biologics work for people with asthma or COPD. Biologics are special shots that target certain parts of the immune system to reduce inflammation. Researchers want to see if these treatments can help control symptoms and prevent flare-ups.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06267378Recruiting
Frailty and its effects on older patients having major gut surgery
This study looks at how frailty affects recovery and outcomes for patients aged 70 and older who are having planned surgery to remove colorectal cancer. The goal is to better understand frailty's impact so care can be improved.
Doncaster, South YorkshireAges 18 years+ - NCT06491472RecruitingPhase 2
Ivonescimab with radiation and chemo for pancreatic cancer
This trial tests a new immunotherapy drug (ivonescimab) combined with targeted radiation and chemotherapy for people with pancreatic cancer. The goal is to see if this combination can shrink tumors and improve outcomes.
WuhanAges 18 years+ - NCT06560047Recruiting
Early catheter ablation for atrial fibrillation with heart failure
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
AalborgAges 18–80 - NCT07741006Enrolling by invitationEarly Phase 1
PET imaging study for adults with solid tumors
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
Wuhan, HubeiAges 18 years+ - NCT07731126Recruiting
Supporting hospital-to-home transition with AI
This trial uses an AI-powered digital assistant to help older adults move safely from hospital to home. It may help you manage your recovery with personalized support.
AnconaAges 65 years+ - NCT06023888Recruiting
Heart rhythm analysis for persistent atrial fibrillation
This study tests a new way to analyze heart signals in people with long-standing atrial fibrillation that hasn't gotten better with medication. It may help doctors understand your heart rhythm better and guide future treatments.
TaipeiAges 20–80 - NCT05914038Recruiting
Personalized brain stimulation to improve arm recovery after stroke
This trial studies whether personalized rTMS (a noninvasive brain stimulation) can help improve arm and hand strength after a recent stroke. It may help people who still have weaker upper-limb movement within the first few months after stroke.
Taipei County, TaipeiAges 20 years+ - NCT07694687Recruiting
Studying a tool to spot confusion in intensive care patients
This study tests a new way to check for delirium (sudden confusion) in patients staying in the intensive care unit (ICU). It also looks at how family members can help spot these changes, so the care team can help sooner.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07689656RecruitingPhase 1/Phase 2
PET imaging study for prostate cancer using a new tracer
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
Wuhan, HubeiAges 18–80 - NCT07677319Recruiting
Heart surgery after age 75: a study on recovery
This study looks at how well people aged 75 and older recover after emergency heart surgery. It uses a special test to measure frailty and quality of life for one year after surgery.
Bordeaux, FranceAges 75 years+ - NCT07677410Recruiting
Aspirin alone vs. aspirin with warfarin after TAVR for aortic regurgitation
This trial tests whether taking aspirin alone is as safe and effective as taking aspirin with warfarin after a TAVR procedure for severe aortic regurgitation. It is for people who do not need long-term blood thinners for other conditions.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07639359RecruitingPhase 2
Ketamine for depression in intensive care patients
This study tests whether low-dose ketamine infusions can reduce depressive symptoms in patients staying in the intensive care unit for at least 6 days. Ketamine is a medication that may work differently than standard antidepressants and could provide faster relief.
Jacksonville, FloridaAges 18–99 - NCT07603583Recruiting
Heart Rate Variability to Detect Sleep Apnea in Hypertension
This study tests whether a simple heart-rate measurement can help detect obstructive sleep apnea (a breathing condition during sleep) in people with high blood pressure. The goal is to find an easier way to screen for sleep apnea, which often goes undiagnosed but can worsen heart health.
Kaohsiung City, KaohsiungAges 18–65 - NCT07597122Recruiting
Blood markers study in septic shock patients
This research study measures special blood markers (microRNAs) in patients with septic shock or critical illness to understand how the body responds to severe infection. Results may help doctors better diagnose and treat sepsis in the future.
BernAges 18 years+ - NCT04469517Recruiting
Study of low-oxygen factors in hereditary bleeding disorder
This study looks at how “low-oxygen” signals may affect people with hereditary hemorrhagic telangiectasia (HHT), a genetic bleeding disorder. It may help researchers understand what drives symptoms and could guide future treatments.
Essen, North Rhine-WestphaliaAges 18 years+
Hear when a new Hospitalized Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized patients?
- Yes. Clin2 currently lists 3,422 recruiting hospitalized patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.